BASEL, Switzerland--(BUSINESS WIRE)--Bayer announced today that the company will invest €100 million to further enable sustainable innovation, production and consumption of our Consumer Health ...
Contract research organization Hesperos announced the publication of a peer-reviewed study developed in conjunction with Bayer Consumer Health. The study, published in Biomedicine and Pharmacology, ...
Hesperos, Inc. (Hesperos), a global leader focused on improving preclinical drug development, food, cosmetic, and chemical testing with its Human-on-a-Chip(R) (HoaC) single- and multi-organ systems ...
and Arno Schuetze Reuters Nov 26, 2018 Nov 26, 2018 0 Bayer will discuss selling certain consumer health brands at a supervisory board meeting this week and will also review options for its animal ...
The MarketWatch News Department was not involved in the creation of this content. Bayer(R) Aspirin Continues Longstanding Commitment to Heart Health Education, Encouraging Americans to "See Their ...
Bayer today announced it has partnered with actress and menopause advocate Gabrielle Union-Wade on the ‘Life Doesn’t Stop for ...
Bayer has selected Interpublic to handle global media, creative and production services for its consumer health division after a formal review, the companies have confirmed. Bayer made a point of ...
TipRanks on MSN
Bayer Tests Talcid in Real-World Acid Rebound Study: What It Means for BAYRY Investors
Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.
Evaluating the effectiveness of a creative ad remains a critical, ongoing consideration for health brands. Improving content quality is more than just an exercise in creative pride; there are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results